Categories: LATEST NEWS

Check-Cap and GE Healthcare Achieve Development Milestone in High-volume X-Ray Capsule Manufacturing Collaboration

Check-Cap Ltd. (NASDAQ: CHEK, CHEKW), a clinical-stage company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening and GE Healthcare (NYSE: GE) today announced the companies have successfully achieved the initial milestone in their ongoing collaboration to develop high-volume, X-ray capsule manufacturing capabilities. Specifically, X-ray sources produced at GE Healthcare using a customized manufacturing method passed all  tests required to ensure compliance with C-Scan® system specifications.

“We are very excited to have achieved success in the first critical phase of our collaboration with GE Healthcare, where we demonstrated the capability of our process to manufacture X-ray sources for the C-Scan® system,” said Bill Densel, CEO of Check-Cap. “We look forward to moving ahead with the development and validation of scalable production and integration processes that can provide capsules for future U.S. clinical trials and commercialization.”

Colorectal cancer is the second leading cause of cancer death in the U.S., with an estimated 135,000 diagnoses and 50,000 deaths in 2017[1].  Despite compelling evidence that screening can detect colorectal cancer and precancerous polyps, nearly one-third of the recommended adult population has never been screened. The C-Scan® system is designed to improve the patient experience with screening  by eliminating many unattractive requirements, such as bowel preparation, fasting, and sedation.

“The results of this critical phase of the collaboration are incredibly exciting for patients and the future prevention of colorectal cancer,” said Emmanuel Ligner, General Manager of Core Imaging for GE Healthcare Life Sciences. “GE Healthcare will continue its collaboration with Check-Cap using our expertise in radiopharmaceutical and device manufacturing to bring the C-Scan® system to clinicians and patients.”

1 “Key Statistics for Colorectal Cancer,” American Cancer Society, https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html

Liat

Comments are closed.

Recent Posts

BeyondTrust Acquires Entitle, Strengthening Privileged Identity Security Platform with Paradigm Shifting Just-in-Time Access and Identity Governance

Entitle is a pioneering privilege management solution that discovers, manages, and automates just-in-time (JIT) access and modern identity governance and…

3 weeks ago

Samtec Introduces SIBORG Tool to Speed Component Launch Designs

Available freely to Samtec customers under NDA, SIBORG (Signal Integrity Breakout Region Guru) works with Ansys HFSS 3D Layout to…

3 weeks ago

Accelerating Mass Business AI Adoption: NeuReality Launches Developer Portal for NR1 Inference Platform, Expanding Affordable AI Access

Entire NR1 system purpose-built for a more affordable AI infrastructure allowing for faster deployment; furthering AI’s reach into more parts…

3 weeks ago

Dot Compliance Raises a $17.5 Million Up-Round in Series B Extension Funding to Advance New Category of AI-driven Compliance

Following rapid growth in its customer base to over 400, funding will fuel further AI development and create a hybrid…

3 weeks ago

Tektronix and recently acquired EA Elektro-Automatik now offer expanded power portfolio for engineers who are electrifying our world

The addition of EA’s high-efficiency regenerative power supplies greatly expands Tektronix’s trusted offering Tektronix, Inc, a leading provider in test…

3 weeks ago

Melexis unveils fully integrated inductive switch

Melexis reveals its groundbreaking Induxis® switch, the MLX92442. Contactless, magnet-free, and strayfield immune, this monolithic solution directly detects conductive targets.…

3 weeks ago